The findings were published today in the New England Journal of Medicine.Article
Sounds promising that this drug not only stops MS from advancing in patients with early stage active relapsing-remitting multiple sclerosis (RRMS) but may also restore lost function caused by the disease.
I want restoration. :) Let's see and as usual... WAIT.
Twitter Highlights (5/27/12)
7 hours ago


0 comments:
Post a Comment